Foresite Capital is an American

venture capital Venture capital (often abbreviated as VC) is a form of private equity financing that is provided by venture capital firms or funds to startups, early-stage, and emerging companies that have been deemed to have high growth potential or which ha ...

and

growth equity Growth capital (also called expansion capital and growth equity) is a type of private equity investment, usually a Minority interest, minority investment, in relatively mature companies that are looking for capital to expand or restructure operatio ...

firm headquartered in

San Francisco San Francisco (; Spanish language, Spanish for "Francis of Assisi, Saint Francis"), officially the City and County of San Francisco, is the commercial, financial, and cultural center of Northern California. The city proper is the List of Ca ...

. As of March 2021, the company had raised four funds: Foresite Capital Fund I, II, III, IV and V.

History

Foresite Capital was founded in 2011 by Jim Tananbaum. Foresite Capital raised its $100 million Fund I in 2013. In 2014, Foresite Capital closed Foresite Capital Fund II, a $300 million fund. Foresite Capital Fund III, a $450 million fund, was closed in July 2015. Foresite Capital Fund IV, a $668 million fund, closed in March 2018. Foresite Capital Fund V, a $969 million fund, was closed in February 2021.

Investments

Foresite Capital funded

10x Genomics 10x Genomics, Inc. is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. It was founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness. History 10x Genomics was founde ...

since its Series A round in November 2013 and led its Series B round in January 2015, as well as its Series C round in March 2016. Foresite Capital has invested in companies such as

Acceleron Pharma Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which p ...

, Aimmune, ALX Oncology,

Aerie Pharmaceuticals Aerie Pharmaceuticals Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Aerie's two lead product candi ...

, Ascendis, Blueprint Medicines,

Color Genomics Color is a population health technology company which provides genetic tests and analysis directly to patients as well as through employers. The product focuses on genes that indicate risk for heart disease, cancer, and that affect medication resp ...

, Cue Health, Cytokinetics, DNAnexus,

Editas Medicine Editas Medicine, Inc., (formerly Gengine, Inc.), is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has ...

, Eikon Therapeutics, Epizyme, Evonetix,

Intarcia Therapeutics Intarcia Therapeutics is an American biopharmaceutical company based in Boston, MA and incorporated under the laws of Delaware. It was founded in 1995 under the name "BioMedicines" and changed to its present name in 2004. In 2013, Intarcia relocat ...

, Inscripta,

Immunomedics Immunomedics was a biotechnology company focused on the development of antibody-drug conjugates for the treatment of cancer. In 2020, the company was acquired by Gilead Sciences. History Immunomedics was founded in July 1982 by David M. Goldenbe ...

Intellia Therapeutics Intellia Therapeutics is a clinical-stage biotechnology company focused on developing novel, potentially curative therapeutics leveraging CRISPR-based technologies. To fully realize the transformative potential of CRISPR-based technologies, Inte ...

Juno Therapeutics Juno Therapeutics Inc is an American biopharmaceutical company founded in 2013 through a collaboration of the Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and pediatrics partner Seattle Children's Research Instit ...

, Karyopharm, Keryx, Kura Oncology, Keros Therapeutics, Maze Therapeutics, MyoKardia, MyOme,

Natera Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology ...

, Nurix, Olema Oncology, Orexigen,

Pacific Biosciences Pacific Biosciences of California, Inc. (aka PacBio) is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio describes its platfor ...

, Peloton Therapeutics, Pharvaris, MindStrong Health, Quantum-SI, Relay Therapeutics, Insitro, HealthVerity, Turning Point Therapeutics, Element Biosciences,

Portola Pharmaceuticals Portola Pharmaceuticals is an American clinical stage biotechnology company that researches, develops, and commercializes drugs. The company focuses primarily on drugs used in the treatment of thrombosis and hematological malignancies. Founded i ...

, Universal American, Xencor, and WaveTech, in addition to

Leadership

Foresite Capital is led by

Midas List The ''Forbes'' Midas list is the annual ranking by ''Forbes'' magazine of the most influential and best-performing venture capital investors. Described by Kara Swisher as the "Oscars for venture capitalists in tech," the Midas List uses parameter ...

honoree Jim Tananbaum along with managing directors Matt Buten, Alisa Mall, Dorothy Margolskee, Michael Rome, Dennis Ryan, and Vikram Bajaj.

References

{{reflist, 2 Financial services companies established in 2011 Venture capital firms of the United States American companies established in 2011